Regenerative medicine holds the promise of providing disruptive medical therapies to improve quality of life and cure untreatable conditions.
Rion harnesses the regenerative power of exosomes to drive the healing potential within the body. Rion's innovative off-the-shelf biologics platforms reduce manufacturing expense paving the path to cost effective and reproducible regenerative therapies.
We are a GMP, and R&D Commercialized Regenerative Medicine Company Focused on the Discovery and Production of Low-Cost, Off-the-Shelf Regenerative Technologies, and Therapies.
We are leveraging our Purified Exosome Population (PEP) regenerative platform to establish cell-therapy safety and efficacy in areas of unmet clinical needs, with significant and wide-reaching addressable markets.
REAdILY-AVAILABLE ProDUCT and ThOSE IN DEvELOPMENT
Rion’s flagship exosome product PEP, stems from a naturally occurring healing signal within the body.
PEP technology powers four advanced (RioPEP, RioGEL, RioDERM, RioCOR) and two emerging (RioMESH and RioGENE) product lines to serve a broad array of medical applications.
Our Advanced Product
Our Emerging Products
Order RIO PEP Today for Your Studies